ArticleCancer research communications2026

Leveraging AI to Evaluate Minimal Residual Disease Endpoint Surrogacy in Multiple Myeloma.

Zexin Ren et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.